Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature Neuroscience

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nn1998PMID 17952067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reelin induces the detachment of postnatal subventricular zone cells and the expression of the Egr-1 through Erk1/2 activation.

  2007cited by this paper
• Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy

  2006cited by this paper
• Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects.

  2005cited by this paper
• Determinants of the nucleocytoplasmic shuttling of muscle glycogen synthase

  2005cited by this paper
• Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.

  2005cited by this paper
• Brain glycogen re‐awakened

  2004cited by this paper
• Mutations in NHLRC1 cause progressive myoclonus epilepsy

  2003cited by this paper
• Control of glycogen deposition

  2003cited by this paper
• Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes.

  2003cited by this paper
• Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.

  2003cited by this paper
• Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.

  2003cited by this paper
• Liver Glycogen Synthase but Not the Muscle Isoform Differentiates between Glucose 6-Phosphate Produced by Glucokinase or Hexokinase*

  2002cited by this paper
• A Unique Carbohydrate Binding Domain Targets the Lafora Disease Phosphatase to Glycogen*

  2002cited by this paper
• Lafora's disease: towards a clinical, pathologic, and molecular synthesis.

  2001cited by this paper
• Mutation spectrum and predicted function of laforin in Lafora’s progressive myoclonus epilepsy

  2000cited by this paper
• Protein targeting to glycogen mRNA expression is stimulated by noradrenaline in mouse cortical astrocytes

  2000cited by this paper
• Identification of Binding Sites on Protein Targeting to Glycogen for Enzymes of Glycogen Metabolism*

  2000cited by this paper
• Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites.

  2000cited by this paper
• A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).

  1999cited by this paper
• Corpora-amylacea and the family of polyglucosan diseases.

  1999cited by this paper
• Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

  1998cited by this paper
• Overexpression of Protein Targeting to Glycogen (PTG) in Rat Hepatocytes Causes Profound Activation of Glycogen Synthesis Independent of Normal Hormone- and Substrate-mediated Regulatory Mechanisms*

  1998cited by this paper
• Proteasome inhibitors: valuable new tools for cell biologists.

  1998cited by this paper
• PTG, a Protein Phosphatase 1-Binding Protein with a Role in Glycogen Metabolism

  1997cited by this paper
• The role of glucose 6‐phosphate in the control of glycogen synthase

  1997cited by this paper
• Muscle glycogen synthase translocates from the cell nucleus to the cytosol in response to glucose

  1997cited by this paper
• Glucose 6-Phosphate Produced by Glucokinase, but Not Hexokinase I, Promotes the Activation of Hepatic Glycogen Synthase*

  1996cited by this paper
• Familial Progressive Myoclonus Epilepsy: Clinical and Electrophysiologic Observations

  1995cited by this paper
• Use of recombinant adenovirus for metabolic engineering of mammalian cells.

  1994cited by this paper
• Rabbit skeletal muscle glycogen synthase expressed in COS cells. Identification of regulatory phosphorylation sites.

  1994cited by this paper
• Progressive Myoclonus Epilepsies: Clinical and Genetic Aspects

  1993cited by this paper
• [Production of monoclonal antibody that recognizes glycogen and its application for immunohistochemistry].

  1993cited by this paper
• Longitudinal Clinicoelectrophysiologic Study of a Case of Lafora Disease Proven by Skin Biopsy

  1990cited by this paper
• A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5.

  1988cited by this paper
• Progressive myoclonus epilepsies: specific causes and diagnosis.

  1986cited by this paper
• Clinical and Genetic Aspects

  1980cited by this paper
• Glycogen synthase: A new activity ratio assay expressing a high sensitivity to the phosphorylation state

  1979cited by this paper
• A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Studies in myoclonus epilepsy (Lafora body form)

  1970cited by this paper
• Myoclonus epilepsy with Lafora bodies. An ultrastruc- tural and cytochemical study.

  1968cited by this paper
• A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.

  1968cited by this paper
• Myoclonus epilepsy with Lafora bodies. An ultrastruc- tural and cytochemical study.

  1968cited by this paper
• d-Glucose-6-phosphate and d-Fructose-6-phosphate: Determination with Glucose-6-Phosphate Dehydrogenase and Phosphoglucose Isomerase

  1965cited by this paper
• On the nature of rabbit liver glycogen. II. Iodine absorption spectrum.

  1951cited by this paper
• On the nature of rabbit liver glycogen. I. Branching characteristics.

  1951cited by this paper
• Über das Vorkommen amyloider Körperchen im Innern der Ganglienzellen

  1911cited by this paper
• Beitrag zur Histopathologie der myoklonischen Epilepsie

  1911cited by this paper
• Nature Neuroscience

  year unknowncited by this paper

• Metabolic interactions in the brain: the crucial roles of neurons, astrocytes, and microglia in health and disease.

  2026cites this paper
• Astrocytic PYGM attenuates tau pathology by promoting lactate‐mediated neuroprotection

  2026cites this paper
• Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for Lafora Disease

  2025cites this paper
• In Situ Lighting-Up Near-Infrared Metabolic Probes for Super-Resolution Imaging of Glycogen.

  2025cites this paper
• Identification of Plasma Growth Factors and Cytokines as Diagnostic Biomarkers for the Lafora Form of Progressive Myoclonus Epilepsy

  2025cites this paper
• Advances in gene therapy for Lafora disease: Intravenous recombinant adeno‐associated virus‐mediated delivery of EPM2A and EPM2B genes

  2025cites this paper
• Discovery and Evaluation of Active Site-Directed, Potent, and Selective Sulfophenyl Acetic Amide-Based Inhibitors for the Laforin Phosphatase.

  2025cites this paper
• Protein glycosylation and synaptic transmission: brain glycogen keeps them separated.

  2025cites this paper
• Joan J. Guinovart (1947-2025).

  2025cites this paper
• Temporal Interactome Mapping of Human Tau in Drosophila Reveals Progressive Mitochondrial Engagement and Porin/VDAC1-Dependent Modulation of Toxicity

  2025cites this paper
• Astrocytes Regulate Brain State Transitions

  2025cites this paper
• Astrocyte-Neuron Metabolic Synergies in Neurological Homeostasis and Disease

  2025cites this paper
• Glycogen supports glycolytic plasticity in neurons

  2025cites this paper
• Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in Epm2b-Deficient Mice

  2025cites this paper
• Ubiquitination of glucose and lipid metabolic proteins is altered in diabetic rat livers.

  2025cites this paper
• Inactivation of Laforin Phosphatase and Increased Glucose Uptake Underlie Glycogen Synthase-Mediated Neuronal Survival Under Oxidative Stress

  2025influential citation
• Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan-associated neurodegenerative disease

  2025cites this paper
• Myofiber-type-dependent ‘boulder’ or ‘multitudinous pebble’ formations across distinct amylopectinoses

  2024cites this paper
• Neuron–astrocyte metabolic coupling facilitates spinal plasticity and maintenance of inflammatory pain

  2024cites this paper
• Gene therapy for Lafora disease in the Epm2a-/- mouse model.

  2024cites this paper
• Glycogen metabolism and structure: A review.

  2024cites this paper
• Mitochondrial pyruvate transport regulates presynaptic metabolism and neurotransmission

  2024cites this paper
• Metabolomics-Based Study of the Protective Effect of 4-Hydroxybenzyl Alcohol on Ischemic Astrocytes

  2024cites this paper
• Differential vulnerability among cell types in the neurovascular unit: Description and mechanisms

  2024cites this paper
• Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice.

  2024cites this paper
• Lafora progressive myoclonus epilepsy: Disease mechanism and therapeutic attempts

  2024cites this paper
• Mitochondrial pyruvate transport regulates presynaptic metabolism and neurotransmission

  2024cites this paper
• Impaired malin expression and interaction with partner proteins in Lafora disease

  2024cites this paper
• Glycogen phosphorylase inhibition improves cognitive function of aged mice

  2023cites this paper
• Late Decrease in Cerebral Blood Flow in Bacterial Meningitis: More than a Simple Normalization of Acute Inflammatory Vessel Wall Architecture?

  2023cites this paper
• Axonal energy metabolism, and the effects in aging and neurodegenerative diseases

  2023cites this paper
• Beneficial Effect of Fingolimod in a Lafora Disease Mouse Model by Preventing Reactive Astrogliosis-Derived Neuroinflammation and Brain Infiltration of T-lymphocytes

  2023cites this paper
• The "molecular soldiers" of the CNS: Astrocytes, a comprehensive review on their roles and molecular signatures.

  2023cites this paper
• Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer’s disease

  2023cites this paper
• ILAE Genetics Literacy series: Progressive myoclonus epilepsies

  2023cites this paper
• Strategies of cerebral protection and neurologic dysfunctions after circulatory arrest: back to the future?

  2023cites this paper
• Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data

  2023cites this paper
• Metabolically regulated spiking could serve neuronal energy homeostasis and protect from reactive oxygen species

  2023cites this paper
• CaMKK2 as an emerging treatment target for bipolar disorder

  2023cites this paper
• The multifaceted roles of the brain glycogen

  2023cites this paper
• Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.

  2022cites this paper
• Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer’s Disease: Current Evidence and Future Avenues

  2022cites this paper
• Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy

  2022cites this paper
• Protein Targeting to Glycogen (PTG): A Promising Player in Glucose and Lipid Metabolism

  2022cites this paper
• Glial Contributions to Lafora Disease: A Systematic Review

  2022cites this paper
• Wasteosomes (corpora amylacea) as a hallmark of chronic glymphatic insufficiency

  2022cites this paper
• The second family affected with a PRDM8-related disease

  2022cites this paper
• Neuron-astrocyte metabolic coupling facilitates spinal plasticity and maintenance of persistent pain

  2022cites this paper
• Testicular Glycogen Metabolism: An Overlooked Source of Energy for Spermatogenesis?

  2022cites this paper
• Glucocorticoid regulation of lactate release from spinal astrocytes contributes to the induction of spinal LTP of C-fiber-evoked field potentials and the development of mechanical allodynia.

  2022cites this paper
• Metabolically driven action potentials serve neuronal energy homeostasis and protect from reactive oxygen species

  2022cites this paper
• Non-lysine ubiquitylation: Doing things differently

  2022cites this paper
• Neuron‐glia (mis)interactions in brain energy metabolism during aging

  2022cites this paper
• Malin restoration as proof of concept for gene therapy for Lafora disease

  2022cites this paper
• Large neutral amino acid levels tune perinatal neuronal excitability and survival

  2022cites this paper
• Time-regulated transcripts with the potential to modulate human pluripotent stem cell-derived cardiomyocyte differentiation

  2022cites this paper
• Brain Metabolic Alterations in Alzheimer’s Disease

  2022cites this paper
• Markers of Hypoxia and Metabolism Correlate With Cell Differentiation in Retina and Lens Development

  2022cites this paper
• The potential mechanisms of lactate in mediating exercise-enhanced cognitive function: a dual role as an energy supply substrate and a signaling molecule

  2022cites this paper
• Molecular architecture of the glycogen- committed PP1/PTG holoenzyme

  2022cites this paper
• Monocarboxylate Transporter 1 May Benefit Cerebral Ischemia via Facilitating Lactate Transport From Glial Cells to Neurons

  2022cites this paper
• Effect of Diet as a Factor of Exposome on Brain Function

  2021cites this paper
• A family study implicates GBE1 in the etiology of autism spectrum disorder

  2021cites this paper
• The rare rs769301934 variant in NHLRC1 is a common cause of Lafora disease in Turkey

  2021cites this paper
• Multiple functions of pyruvate kinase M2 in various cell types

  2021cites this paper
• Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration

  2021cites this paper
• Brain glycogen metabolism: A possible link between sleep disturbances, headache and depression.

  2021cites this paper
• Noradrenaline‐induced l‐lactate production requires d‐glucose entry and transit through the glycogen shunt in single‐cultured rat astrocytes

  2021cites this paper
• An empirical pipeline for personalized diagnosis of Lafora disease mutations

  2021cites this paper
• TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases

  2021cites this paper
• Astrocyte-neuron lactate transport in the ACC contributes to the occurrence of long-lasting inflammatory pain in male mice.

  2021cites this paper
• Adult polyglucosan body disease: an acute presentation leading to unmasking of this rare disorder

  2021cites this paper
• Effects of Late-Life Caloric Restriction on Age-Related Alterations in the Rat Cortex and Hippocampus

  2021cites this paper
• A novel deletion mutation in EPM2A underlies progressive myoclonic epilepsy (Lafora body disease) in a Pakistani family.

  2021cites this paper
• Metabolic regulation of neurodifferentiation in the adult brain

  2020cites this paper
• Astrocyte-Derived Lactate Modulates the Passive Coping Response to Behavioral Challenge in Male Mice

  2020cites this paper
• Discovery and development of small-molecule inhibitors of glycogen synthase.

  2020cites this paper
• C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside

  2020cites this paper
• Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities

  2020cites this paper
• Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity.

  2020cites this paper
• Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress

  2020cites this paper
• The Motor Neuron-Like Cell Line NSC-34 and Its Parent Cell Line N18TG2 Have Glycogen that is Degraded Under Cellular Stress

  2020cites this paper
• Astrocyte-Derived Lactate Modulates the Passive Coping Response to Behavioral Challenge in Male Mice

  2020cites this paper
• Nutrition and Central Nervous System

  2020cites this paper
• The Strategic Location of Glycogen and Lactate: From Body Energy Reserve to Brain Plasticity

  2019cites this paper
• Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways

  2019cites this paper
• [Lafora disease: a review of the literature].

  2019influential citation
• The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease

  2019cites this paper
• The Role of Brain Glycogen in Supporting Physiological Function

  2019cites this paper
• Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.

  2019cites this paper
• Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.

  2019cites this paper
• Metabolism of Glycogen in Brain White Matter.

  2019cites this paper
• Structure and Regulation of Glycogen Synthase in the Brain.

  2019cites this paper
• Glycogen in Astrocytes and Neurons: Physiological and Pathological Aspects.

  2019cites this paper
• Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.

  2019cites this paper
• Nuclear Glycogenolysis Modulates Histone Acetylation in Human Non-Small Cell Lung Cancers.

  2019cites this paper
• The Structure and the Regulation of Glycogen Phosphorylases in Brain.

  2019cites this paper
• Major Advances in Brain Glycogen Research: Understanding of the Roles of Glycogen Have Evolved from Emergency Fuel Reserve to Dynamic, Regulated Participant in Diverse Brain Functions.

  2019cites this paper
• Polyglucosan Bodies in Aged Brain and Neurodegeneration: Cause or Consequence?

  2019cites this paper
• Update on polyglucosan storage diseases

  2019cites this paper